Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Galectin-1, a radioresistance marker, was found in our previous study to be a prognostic factor for cervical cancer. The aim of current study is to determine the prognostic significance of the galectin-1 expression level in patients with glioblastoma multiforme (GBM) undergoing adjuvant radiotherapy (RT). | Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy